Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CORE trial data suggest efficacy of deferasirox in hereditary hemochromatosis

Dec. 9, 2009

Forest identifies novel SCD1 inhibitors for the treatment of obesity

Dec. 7, 2009

FDA approves Novo Nordisk's Vagifem 10 mcg for atrophic vaginitis due to menopause

Dec. 7, 2009

Endo provides regulatory update on Aveed for men with low testosterone

Dec. 4, 2009

Agreement reached on U.S. approval pathway for Pompe disease treatment

Dec. 4, 2009

Bayer Schering Pharma claims novel series of adenosine A1 agonists

Dec. 4, 2009

Roche reports encouraging results from phase III trials of taspoglutide in diabetes

Dec. 4, 2009

FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients

Dec. 4, 2009

EMEA accepts clinical development plan for DiaPep-277

Dec. 3, 2009

Biovitrum discovers novel GPR119 agonists for the treatment of obesity

Dec. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...